Upper gastrointestinal disease in patients with familial adenomatous polyposis

Authors: WALLACE M.H.¹; PHILLIPS R.K.S.^{1, *}

Source: British Journal of Surgery, Volume 85, Number 6, June 1998 , pp. 742-750(9)

Buy & download fulltext article:

The full text article is not available for purchase.

The publisher only permits individual articles to be downloaded by subscribers.

Abstract:

Background Upper gastrointestinal disease has become an important aspect in the management of patients with familial adenomatous polyposis (FAP).

Methods A review of the literature was carried out using Medline. Epidemiology, pathology and treatment options are considered.

Results and conclusion Despite the fact that over 90 per cent of patients with FAP develop duodenal adenomas, only 5 per cent go on to develop cancer. In the absence of methods to detect who is at risk of cancer, all patients undergo regular endoscopic surveillance at present. Chemoprevention in the form of drug therapy may be the answer to controlling the disease.

Language: English

Document Type: Research article

Affiliations: 1: St Mark's Hospital, Northwick Park, Watford Road, Harrow HA1 3UJ, UK *

Publication date: 1998-06-01

More about this publication?

As of January 2010, this journal will no longer be available on IngentaConnect, please visit Wiley InterScience to arrange continued access to this content
Access this journal at Wiley InterScience
ingentaconnect is not responsible for the content or availability of external websites